Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
The British Journal of Psychiatry. Supplement|September 1, 1993
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placeboF M Quitkin, J W Stewart, P J McGrath, et al.
The American Journal of Drug and Alcohol Abuse|July 8, 1999
Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug usersC Dolezal, H F Meyer-Bahlburg, X Liu, et al.
Women & Health|October 31, 1998
Sexual risk behavior changes among HIV+ and HIV-female injecting drug users over 4 yearsC Dolezal, A A Ehrhardt, H F Meyer-Bahlburg, et al.
The Journal of Clinical Psychiatry|July 1, 1984
Psychopharmacologic validation of atypical depressionM R Liebowitz, F M Quitkin, J W Stewart, et al.
Archives of General Psychiatry|September 1, 1989
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depressionF M Quitkin, P J McGrath, J W Stewart, et al.
Psychopharmacology Bulletin|January 1, 1989
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depressionB Parsons, F M Quitkin, P J McGrath, et al.
The American Journal of Psychiatry|February 1, 1991
Different types of placebo response in patients receiving antidepressantsF M Quitkin, P J McGrath, J G Rabkin, et al.
The American Journal of Psychiatry|February 1, 1991
Heterogeneity of clinical response during placebo treatmentF M Quitkin, J G Rabkin, J W Stewart, et al.
Archives of General Psychiatry|April 1, 1991
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover designF M Quitkin, W Harrison, J W Stewart, et al.
The Journal of Biological Chemistry|June 28, 1996
Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementiaS M Fine, R A Angel, S W Perry, et al.
Pageof 18